Tyratech Regulatory News (TYR)

2 Oct 2007 07:01

TyraTech, Inc.02 October 2007 Press Release 2 October 2007 TyraTech Inc. ("TyraTech" or "the Company") Director's Shareholding TyraTech (AIM:TYR), the pioneer of safer, effective and natural pesticideproducts, today announces that on 29 September 2007 Rick Brenner, executiveDirector of the Company, was granted 50,000 common shares of US$0.001 ("CommonShares"). 25,000 of these Common Shares will vest on the first anniversary andthe remaining balance on the second anniversary, providing he is still employedby the Company. At present Mr Brenner does not own any Common Shares in the Company and the50,000 Common Shares represent 0.2 per cent of the current total issued sharecapital of TyraTech. - Ends - For further information: TyraTech Inc. Douglas Armstrong PhD, Chief Executive Officer Tel: +1 (321) 409 7403 www.tyratech.com Nomura Code Securities Charles Walker Tel: +44 (0) 20 7776 1200 www.nomuracode.com Jefferies International Limited Jack Pryde Tel: +44 (0) 20 7618 3500 www.jefferies.com Media enquiries: Abchurch Heather Salmond Tel: +44 (0) 20 7398 7700 heather.salmond@abchurch-group.com Gareth Mead gareth.mead@abchurch-group.com Stephanie Cuthbert stephanie.cuthbert@abchurch-group.com www.abchurch-group.com About TyraTech, Inc. TyraTech is pioneering a new class of highly effective, non-toxic, pesticidesand anti-parasitic compounds to address global agriculture, horticulture,functional foods, healthcare and veterinary markets. Using a revolutionarychemoreceptor screening process, TyraTech has identified natural oils thatstimulate the reactions and biological behaviour of insects and parasites sothat they can be effectively repelled or killed. TyraTech's technology preventsthe development of resistance and avoids the environmental concerns and humanhealth risks of chemical solutions whilst still being at least, if not more,effective. The Company's products have been validated through strong partnerships withmultinational conglomerates operating within a growing US$30 billion worldwidemarket that is being increasingly driven by environmental legislation andend-user demand. TyraTech's discovery platform has been tested and verified by globalcorporations and independent laboratory test facilities around the world. Thesetest results include total mosquito lavicidal mortality in one hour, mosquitorepellent at least equal to DEET, full head lice mortality in less than fiveminutes and complete intestinal parasite mortality in five minutes, amongstothers. TyraTech continues to develop new product applications based on safe, naturalingredients with a broad range of partners around the world. For further information, see www.tyratech.com. This information is provided by RNS The company news service from the London Stock Exchange